Human Papillomavirus Infection
Conditions
Brief summary
The purpose of the study is to determine the Human Papillomavirus (HPV) prevalence and HPV type distribution among women aged \>= 18 years, attending out-patient health services for gynaecological examination and who agree to HPV testing in Egypt .
Interventions
PROCEDUREEndocervical samples
Endocervical samples collection during routine gynaecological examinations.
Sponsors
GlaxoSmithKline
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Women \>= 18 years of age attending a clinic for gynaecological examination. * Women who agree to provide a cervical sample for human papillomavirus testing. * Written informed consent obtained from the subject.
Exclusion criteria
* Referral for abnormal cervical sample at the current visit. * Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed. * History of hysterectomy. * Known diagnosis of immunosuppression, or patient on immunosuppressives. * Pregnant women. * Having received one or more doses of HPV vaccine prior to participating in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of Human papillomavirus (HPV) DNA and of any of the HPV types among women undergoing cervical sample testing. | Average timeframe: 12 months |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of HPV DNA and of any of the HPV types among women of different age-strata undergoing cervical sample testing | Average timeframe: 12 months |
| Behavioural risk factors assessed by behavioral questionnaire | At the single study visit (Day 0) |
| Assessing the awareness of HPV in relation to transmission and cause of cervical cancer | At the single study visit (Day 0) |
Countries
Egypt
Outcome results
None listed